Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APRI

Apricus Biosciences (APRI) Stock Price, News & Analysis

Apricus Biosciences logo

About Apricus Biosciences Stock (NASDAQ:APRI)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$0.0005
$0.0005
50-Day Range
N/A
52-Week Range
$0.18
$3.34
Volume
5 shs
Average Volume
558,386 shs
Market Capitalization
$14,085.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. The firm's portfolio includes several late-stage clinical assets targeting indications including Acute Suicidal Ideation and Behavior in Major Depressive Disorder �or Post-Traumatic Stress Disorder, �amyotrophic lateral sclerosis, Sanfilippo syndrome, Parkinson's disease, other psychiatric and movement disorders plus orphan diseases. The company was founded by Raj Mehra in 2016 and is headquartered in New York, NY.

Remove Ads
Receive APRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apricus Biosciences and its competitors with MarketBeat's FREE daily newsletter.

APRI Stock News Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
See More Headlines

APRI Stock Analysis - Frequently Asked Questions

Apricus Biosciences, Inc. (NASDAQ:APRI) issued its quarterly earnings results on Wednesday, October, 31st. The company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.02.

Based on aggregate information from My MarketBeat watchlists, some other companies that Apricus Biosciences investors own include Scotts Miracle-Gro (SMG), Pfizer (PFE), Just Eat Takeaway.com (GRUB), Boston Beer (SAM), Amicus Therapeutics (FOLD), Palatin Technologies (PTN) and Synergy Pharmaceuticals (SGYP).

Company Calendar

Last Earnings
10/31/2018
Today
4/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:APRI
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$320,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.76 million
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
0.00

Miscellaneous

Free Float
N/A
Market Cap
$14,085.00
Optionable
Not Optionable
Beta
1.20
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:APRI) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners